Hepatitis B virus kinetics and mathematical modeling

Seminars in Liver Disease

Volumn 24, Issue SUPPL. 1, 2004, Pages 11-16

  Perelson, Alan S ^a   Ribeiro, Ruy M ^a,b  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Hepatitis B virus; Modeling; Viral kinetics

Indexed keywords

ADEFOVIR DIPIVOXIL; FAMCICLOVIR; LAMIVUDINE;

ARTICLE; CHRONIC HEPATITIS; CONFERENCE PAPER; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; KINETICS; MATHEMATICAL MODEL; NONHUMAN; PRIORITY JOURNAL; VIROLOGY;

ADENINE; ANTIVIRAL AGENTS; DNA, VIRAL; HEPATITIS B; HEPATITIS B VIRUS; HEPATOCYTES; LAMIVUDINE; MODELS, BIOLOGICAL; PHOSPHONIC ACIDS; REVERSE TRANSCRIPTASE INHIBITORS; VIRAL LOAD; VIRION;

EID: 2942590744     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-828673     Document Type: Conference Paper

References (19)

1. Perelson AS. Modelling viral and immune system dynamics. Nat Rev Immunol 2002;2:28-36
2. Neumann AU, Lam NP, Dahari H, et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 1998;282:103-107
3. Nowak MA, Bonhoeffer S, Hill AM, et al. Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci USA 1996;93:4398-4402
4. Tsiang M, Rooney JF, Toole JJ, Gibbs CS. Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy. Hepatology 1999;29:1863-1869
5. Lewin SR, Ribeiro RM, Walters T, et al. Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed. Hepatology 2001;34:1012-1020
6. Zeuzem S, de Man RA, Honkoop P, et al. Dynamics of hepatitis B virus infection in vivo. J Hepatol 1997;27:431-436
7. Lau GK, Tsiang M, Hou J, et al. Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study. Hepatology 2000;32:394-399
8. Wolters LM, Hansen BE, Niesters HG, de Man RA. Viral dynamics in chronic hepatitis B patients treated with lamivudine, lamivudine-famciclovir or lamivudine-ganciclovir. Eur J Gastroenterol Hepatol 2002;14:1007-1011
9. Wolters LM, Hansen BE, Niesters HG, et al. Viral dynamics during and after entecavir therapy in patients with chronic hepatitis B. J Hepatol 2002;37:137-144
10. Wolters LM, Hansen BE, Niesters HG, et al. The influence of baseline characteristics on viral dynamic parameters in chronic hepatitis B patients treated with lamivudine. J Hepatol 2002;37:253-258
11. Wolters LM, Hansen BE, Niesters HG, et al. Viral dynamics in chronic hepatitis B patients during lamivudine therapy. Liver 2002;22:121-126
12. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-122
13. Perelson AS, Neumann AU, Markowitz M, et al. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996;271:1582-1586
14. Ho DD, Neumann AU, Perelson AS, et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-126
15. Guidotti LG, Rochford R, Chung J, et al. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999;284:825-829
16. Herrmann E, Lee JH, Marinos G, et al. Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon. Hepatology 2003;37:1351-1358
17. Perelson AS, Essunger P, Ho DD. Dynamics of HIV-1 and CD4+ lymphocytes in vivo. AIDS 1997;11:S17-S24
18. Whalley SA, Murray JM, Brown D, et al. Kinetics of acute hepatitis B virus infection in humans. J Exp Med 2001;193:847-854
19. Sato H, Orenstein J, Dimitrov D, Martin M. Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles. Virology 1992;186:712-724